Volume 13, Number 12—December 2007
Research
Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus, United States, 1999–2005
Eili Klein*, David L. Smith†, and Ramanan Laxminarayan*
Table 2
Hospitalizations and rates of infections with Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) by region and year, United States*
| Region | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 |
|---|---|---|---|---|---|---|---|
| Northeast | 8.42 (3.58) | 8.61 (3.9) | 10.01 (4.9) | 10.62 (5.22) | 11.25 (5.65) | 11.07 (5.84) | 11.59 (6.12) |
| Midwest | 8.53 (3.84) | 9.59 (4.53) | 9.8 (4.84) | 9.33 (4.8) | 9.65 (5.04) | 11.29 (6.54) | 12.47 (7.23) |
| South | 9.71 (4.63) | 9.44 (4.68) | 10.14 (5.33) | 11.17 (6.15) | 12.5 (7.25) | 13.46 (8.21) | 14.77 (9.31) |
| West | 9.75 (3.15) | 8.33 (3.14) | 10.85 (4.61) | 11.05 (4.98) | 11.57 (5.87) | 13.75 (7.39) | 15.84 (8.55) |
*Rates are no. hospitalizations with S. aureus MRSA–related discharge diagnoses/1,000 discharges. Values in parentheses are rates for MRSA.
